Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Scheiflinger

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Blood|January 15, 2009
Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapyPablo Laje, Dezhi Shang, Wenjing Cao, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 1, 2015
Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypassCharles L Percy, Rudolf Hartmann, Rhidian M Jones, et al.
Blood|August 24, 2012
Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in miceSimon F De Meyer, Alexander S Savchenko, Michael S Haas, et al.
Haematologica|November 19, 2013
Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpuraSilvia Ferrari, Kristina Palavra, Bernadette Gruber, et al.
Blood|April 14, 2005
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case reportMiriam Galbusera, Elena Bresin, Marina Noris, et al.
Blood|March 2, 2016
ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in miceFrederik Denorme, Friederike Langhauser, Linda Desender, et al.
EMBO Molecular Medicine|August 25, 2017
Genome editing for scalable production of alloantigen-free lentiviral vectors for <i>in vivo</i> gene therapyMichela Milani, Andrea Annoni, Sara Bartolaccini, et al.
Clinical Immunology (Orlando, Fla.)|November 4, 2018
IVIG induces apoptotic cell death in CD56<sup>dim</sup> NK cells resulting in inhibition of ADCC effector activity of human PBMCSebastian Bunk, Padmapriya Ponnuswamy, Azra Trbic, et al.
The Journal of Biological Chemistry|November 27, 2013
Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI)Michael Dockal, Rudolf Hartmann, Markus Fries, et al.
Human Gene Therapy Methods|February 9, 2019
Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive <i>In Vitro</i> AssaysAnita Kruzik, Herwig Koppensteiner, Damir Fetahagic, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Blood|January 15, 2009
Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapyPablo Laje, Dezhi Shang, Wenjing Cao, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 1, 2015
Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypassCharles L Percy, Rudolf Hartmann, Rhidian M Jones, et al.
Blood|August 24, 2012
Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in miceSimon F De Meyer, Alexander S Savchenko, Michael S Haas, et al.
Haematologica|November 19, 2013
Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpuraSilvia Ferrari, Kristina Palavra, Bernadette Gruber, et al.
Blood|April 14, 2005
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case reportMiriam Galbusera, Elena Bresin, Marina Noris, et al.
Blood|March 2, 2016
ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in miceFrederik Denorme, Friederike Langhauser, Linda Desender, et al.
EMBO Molecular Medicine|August 25, 2017
Genome editing for scalable production of alloantigen-free lentiviral vectors for <i>in vivo</i> gene therapyMichela Milani, Andrea Annoni, Sara Bartolaccini, et al.
Clinical Immunology (Orlando, Fla.)|November 4, 2018
IVIG induces apoptotic cell death in CD56<sup>dim</sup> NK cells resulting in inhibition of ADCC effector activity of human PBMCSebastian Bunk, Padmapriya Ponnuswamy, Azra Trbic, et al.
The Journal of Biological Chemistry|November 27, 2013
Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI)Michael Dockal, Rudolf Hartmann, Markus Fries, et al.
Human Gene Therapy Methods|February 9, 2019
Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive <i>In Vitro</i> AssaysAnita Kruzik, Herwig Koppensteiner, Damir Fetahagic, et al.
Pageof 9